| 7161 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Salmonella Typhi Infections Associated with Contaminated Water - Zimbabwe, October 2011-May 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| sub-Saharan African countries | 0.528723 |
| sewer blockages compound | 0.52582 |
| typhoid fever | 0.920307 |
| Human Services | 0.517748 |
| remediate existing boreholes | 0.547527 |
| safe water | 0.603314 |
| Laboratory Training Program | 0.671775 |
| water needs | 0.508226 |
| MMWR HTML versions | 0.529698 |
| U.S. Department | 0.517314 |
| typhoid fever prevention | 0.603393 |
| old cast-iron pipes | 0.531372 |
| safe food preparation | 0.542614 |
| electronic PDF version | 0.527838 |
| water samples | 0.514706 |
| Zoonotic Infectious Diseases | 0.524542 |
| public boreholes | 0.4951 |
| South Africa Field | 0.555342 |
| Medical Research Institute | 0.671367 |
| endemic typhoid fever | 0.601611 |
| City Health Department | 0.586184 |
| CDC-Kenya/Kenya Medical Research | 0.553755 |
| drilling new ones | 0.523567 |
| Katherine A. O'Connor | 0.518003 |
|
| Kenya Medical Research | 0.52345 |
| Public health partners | 0.55443 |
| health education messages | 0.553556 |
| original paper copy | 0.522397 |
| Harare City Health | 0.754798 |
| City Health Dept | 0.54747 |
| single 20-liter bucket | 0.531432 |
| safe water collection | 0.579687 |
| original MMWR paper | 0.5352 |
| U.S. Government Printing | 0.529736 |
| Rachel B. Slayton | 0.623828 |
| limited surveillance systems | 0.533067 |
| shallow wells | 0.601368 |
| drinking water | 0.559356 |
| contaminated water | 0.510135 |
| suspected cases | 0.548734 |
| dichloroisocyanurate water-purification tablets | 0.536376 |
| Peter H. Kilmarx | 0.525317 |
| new polyvinyl chloride | 0.532073 |
| water supply | 0.51028 |
| South African Field | 0.529023 |
| municipal taps | 0.528593 |
| unimproved water sources | 0.577296 |
| local reservoir tanks | 0.525714 |
|
CLICK HERE |
| 9153 |
Centers for Disease Control and Prevention |
Html |
en |
Investigation of Hepatitis E Outbreak Among Refugees - UpperNile, South Sudan, 2012-2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| acute viral hepatitis | 0.463722 |
| Jamam camp | 0.649653 |
| HEV vaccine | 0.647552 |
| symptomatic HEV infection | 0.57019 |
| HEV infections | 0.538134 |
| Jamam refugee camp | 0.451322 |
| HEV outbreak control | 0.612997 |
| AJS case-fatality rate | 0.480057 |
| CDC-Kenya Medical Research | 0.448236 |
| HEV preventive hygiene | 0.589339 |
| Yusuf Batil camp | 0.44745 |
| AJS attack rates | 0.454469 |
| pregnant women | 0.96966 |
| HEV prevention | 0.540999 |
| South Sudan Ministry | 0.747228 |
| AJS patients | 0.490798 |
| Medical Research Institute | 0.448909 |
| Maban County | 0.458181 |
| active case finding | 0.45245 |
| Yusuf Batil | 0.695766 |
| HEV infection | 0.780637 |
| World Health Organization | 0.586424 |
| Maban County refugee | 0.455854 |
| cumulative hospital CFR | 0.447555 |
| South Sudan | 0.93203 |
|
| Large HEV outbreaks | 0.646016 |
| HEV incubation period | 0.56767 |
| HEV transmission | 0.529226 |
| viral AJS etiologies | 0.4865 |
| AJS cases | 0.645874 |
| prior HEV infection | 0.581258 |
| MУЉdecins Sans FrontiУЈres | 0.53197 |
| Nations High Commissioner | 0.728402 |
| acute jaundice syndrome | 0.559416 |
| Subsequent AJS cases | 0.490155 |
| hygiene conditions | 0.44848 |
| HEV cases | 0.556766 |
| United Nations High | 0.462323 |
| Research Institute laboratory | 0.449581 |
| Global Health Protection | 0.458301 |
| newly developed HEV | 0.612704 |
| HEV genotype | 0.531702 |
| HEV outbreaks | 0.714312 |
| Yusuf Batil refugee | 0.48939 |
| past HEV infection | 0.577665 |
| Batil refugee camps | 0.477944 |
| initial AJS cases | 0.494891 |
| HEV | 0.909412 |
| series HEV vaccine | 0.573147 |
|
CLICK HERE |
| 9707 |
Centers for Disease Control and Prevention |
Html |
es |
Artículos de la campaña para el público hispano - Recursos de la campaña - Consejos de exfumadores |
Este artículo previamente escrito para la prensa sobre la campaña Consejos de exfumadores puede ser adaptado y utilizado por periodistas, blogueros y otros miembros de los medios de comunicación. |
| Archivo Apple Quicktime | 0.45676 |
| llamada tomorro rose | 0.576172 |
| temprana edad | 0.561359 |
| afirma rose | 0.755389 |
| Archivo Adobe PDF | 0.454164 |
| Archivo Microsoft | 0.725812 |
| Emotivos anuncios | 0.415877 |
| Archivo Microsoft Word | 0.467739 |
| claro —tanto | 0.410126 |
| Archivo Texto | 0.393431 |
| obstructiva crónica | 0.395399 |
| niños varones | 0.394934 |
| Archivo Microsoft Excel | 0.4556 |
| tabaquismo cala | 0.455703 |
|
| pequeña localidad | 0.401653 |
| Archivo RealPlayer | 0.399401 |
| campaña consejos | 0.995372 |
| Archivo Microsoft PowerPoint | 0.469306 |
| Estados Unidos | 0.530757 |
| principales causas | 0.557718 |
| 7.8Â % fuma cigarrillos | 0.524011 |
| fuma cigarrillos | 0.637532 |
| Archivo Zip Comprimido | 0.456044 |
| origen puertorriqueño | 0.404718 |
| Nueva York | 0.579531 |
| valientes mujeres | 0.410911 |
| dentadura postiza | 0.689627 |
| emotivas historias | 0.400702 |
|
CLICK HERE |
| 9826 |
Centers for Disease Control and Prevention |
Html |
en |
Q Fever - Prevention - CDC |
Q fever is a worldwide disease with acute and chronic stages caused by the bacteria Coxiella burnetii. |
| facilities housing sheep | 0.863538 |
| milk products | 0.671029 |
| United States | 0.665053 |
| vaccines | 0.389475 |
| Occupational Exposure | 0.658114 |
| extra precautions | 0.643608 |
| fever | 0.896199 |
| immunosuppression | 0.415793 |
| dairy workers | 0.60973 |
| non–pasteurized milk | 0.671853 |
| veterinarians | 0.367809 |
| acute Q fever | 0.891081 |
| contact | 0.353487 |
| MMWR R&R | 0.600051 |
|
| animals | 0.431826 |
| heart valve disease | 0.874756 |
| C. burnetii | 0.684586 |
| researchers | 0.348863 |
| Certain professions | 0.652397 |
| goats | 0.356698 |
| People | 0.347831 |
| birth | 0.353139 |
| meat processing plant | 0.884626 |
| history | 0.348287 |
| chronic Q fever | 0.872192 |
| healthcare provider | 0.601393 |
| risk | 0.425051 |
| livestock farmers | 0.631389 |
|
CLICK HERE |
| 10313 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00329 - Multistate Outbreak of Fungal Meningitis |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| injectable NECC product | 0.735432 |
| CDC treatment guidance | 0.523971 |
| NECC facility | 0.571612 |
| CDC | 0.644651 |
| possible fungal meningitis | 0.534271 |
| MedWatch Safety Alert | 0.765392 |
| public health departments | 0.65709 |
| fungal infection | 0.515453 |
| elevated white cell | 0.491232 |
| Disease Control | 0.499943 |
| NECC products | 0.650181 |
| state health departments | 0.495034 |
| clinicians | 0.495369 |
| public health department | 0.490295 |
| ongoing patient notification | 0.49013 |
| methylprednisolone acetate injection | 0.555572 |
| England Compounding Center | 0.691725 |
| eye surgery | 0.546803 |
| patients | 0.572056 |
| deep brain stroke | 0.490474 |
| preservative-free methylprednisolone acetate | 0.601197 |
| ophthalmic drug | 0.547377 |
| symptoms | 0.48982 |
| methylprednisolone acetate | 0.973799 |
|
| FDA issuance | 0.483839 |
| FDA website | 0.514981 |
| diagnostic evaluation | 0.491026 |
| New England Compounding | 0.684333 |
| state public health | 0.67268 |
| Aspergillus fumigatus | 0.506529 |
| fungal meningitis | 0.800852 |
| CDC Health Alert | 0.562321 |
| FDA | 0.597839 |
| methylprednisolone acetate products | 0.525445 |
| thorough diagnostic evaluation | 0.48325 |
| enhances health decisions | 0.484425 |
| critical health issues | 0.488525 |
| cardiac transplant patient | 0.48796 |
| fungus Aspergillus fumigatus | 0.498323 |
| NECC cardioplegic solution | 0.625134 |
| Aspergillus fumigatus infection | 0.500582 |
| peripheral joint infections | 0.589562 |
| Safety Alert notice | 0.484885 |
| fungal infections | 0.529195 |
| new neurological deficit | 0.494167 |
| steroid injectable product | 0.576404 |
| NECC | 0.849461 |
| fungus Exserohilum rostratum | 0.493665 |
|
CLICK HERE |
| 11161 |
Centers for Disease Control and Prevention |
Html |
en |
CDC announces the formation of an external laboratory safety workgroup | Media Statement | CDC Online Newsroom | CDC |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| CDC Director | 0.567286 |
| National Biosafety | 0.666844 |
| infectious diseases | 0.82771 |
| H5N1 influenza-containing laboratory | 0.551257 |
| environmental health | 0.589144 |
| †Certified Biological Safety | 0.558637 |
| Biological Safety Association | 0.913309 |
| Health Inspection Services | 0.567992 |
| Duke University | 0.571632 |
| American Biological Safety | 0.913345 |
| CDC BSL-2 facilities | 0.575469 |
| UTMB Institutional Biosafety | 0.593433 |
| biological laboratory safety | 0.59639 |
| Scientific Counselors | 0.556595 |
| University Safety Committee | 0.612477 |
| National Science Advisory | 0.617246 |
| Scientific Advisory Board | 0.702325 |
| Chemical Safety Program | 0.54628 |
| Livermore National Laboratory | 0.544886 |
| European Biosafety Association | 0.601389 |
| Biosafety programs | 0.557895 |
| CDC’s laboratories | 0.548999 |
| University Institutional Biosafety | 0.647126 |
| NIH’s National | 0.564529 |
| public health laboratories | 0.636247 |
|
| Public Health England | 0.557946 |
| health reference laboratory | 0.569047 |
| University Biosafety Officer | 0.639166 |
| external BSL-3 laboratory | 0.549424 |
| Infectious Diseases Laboratory | 0.565977 |
| Science Advisory Board | 0.619462 |
| Biosafety Regulations | 0.550979 |
| CDC BSL-3 facility | 0.578478 |
| Animal Biosafety Level | 0.598804 |
| National Health Security | 0.574944 |
| Regional Biocontainment Laboratory | 0.557578 |
| Institutional Biosafety Committee | 0.690222 |
| public health | 0.851519 |
| Certified Biological Safety | 0.576564 |
| CDC laboratories | 0.547595 |
| Biological Safety Professional | 0.642769 |
| Biosafety Professional | 0.556796 |
| Corporate BioSafety Programme | 0.589351 |
| Biocontainment Training Program | 0.705347 |
| laboratory safety | 0.649791 |
| Environmental Safety Office | 0.569915 |
| laboratory safety workgroup | 0.614716 |
| public health preparedness | 0.669479 |
| public health laboratory | 0.598784 |
|
CLICK HERE |
| 11307 |
Centers for Disease Control and Prevention |
Html |
en |
Childhood Lead Poisoning Prevention Program - PLPYC 91 Appendix 1 |
The Childhood Lead Poisoning Prevention Program is committed to the Healthy People goal of eliminating elevated blood lead levels in children by 2020. CDC continues to assist state and local childhood lead poisoning prevention programs, to provide a scientific basis for policy decisions, and to ensure that health issues are addressed in decisions about housing and the environment. |
| small manual lancet | 0.526777 |
| Generalized procedure finger | 0.625248 |
| lead contamination | 0.55858 |
| Childhood Lead Poisoning | 0.612294 |
| fingerstick collection procedures | 0.578262 |
| best collection procedure | 0.592047 |
| blood collection | 0.57265 |
| stick blood samples | 0.562617 |
| sterile gauze | 0.654509 |
| examination gloves | 0.569841 |
| blood flow | 0.680578 |
| collection containers | 0.555471 |
| Lead Poisoning Programs | 0.530714 |
| collection | 0.71178 |
| health laboratory lead | 0.552138 |
| blood lead specimens | 0.649718 |
| lead poisoning | 0.618879 |
| distal joint | 0.526028 |
| collection container | 0.605729 |
| blood lead survey | 0.596814 |
| specimen collection | 0.524194 |
| Inadequate blood flow | 0.580584 |
| new containers | 0.529112 |
| capillary blood | 0.538245 |
|
| stick blood specimens | 0.576058 |
| puncture site | 0.545206 |
| Lead Poisoning Program | 0.532978 |
| collection procedure | 0.599358 |
| blood circulation | 0.526579 |
| diagnostic blood specimens | 0.569172 |
| blood droplets | 0.536293 |
| dilute nitric acid | 0.522999 |
| finger stick blood | 0.857224 |
| index finger | 0.583956 |
| medical waste | 0.581679 |
| specimen integrity | 0.524342 |
| finger | 0.897818 |
| Sterile cotton balls | 0.542923 |
| similar barrier spray | 0.545528 |
| glass capillary tubes | 0.850228 |
| alcohol swabs | 0.591173 |
| middle finger | 0.585708 |
| suitable collection equipment | 0.561088 |
| blood | 0.972013 |
| appropriate waste containers | 0.53971 |
| cotton ball | 0.630594 |
| blood containers | 0.547982 |
| blood lead levels | 0.644298 |
|
CLICK HERE |
| 13344 |
Centers for Disease Control and Prevention |
Html |
en |
Hepatitis C FAQs for the Public | Division of ViralHepatitis | CDC |
null |
| virus transmission | 0.368447 |
| blood tests | 0.350521 |
| newly occurring infection | 0.375488 |
| liver failure | 0.364889 |
| viral infections | 0.353403 |
| different blood tests | 0.349459 |
| acute hepatitis | 0.5908 |
| sexual contact | 0.356034 |
| pregnant woman | 0.353923 |
| chronic liver disease | 0.401108 |
| Hepatitis B virus | 0.529552 |
| Hepatitis B. Research | 0.500698 |
| liver damage | 0.399321 |
| routine blood tests | 0.350405 |
| liver disease | 0.404219 |
| liver | 0.498783 |
| contagious liver disease | 0.398126 |
| liver enzyme level | 0.445091 |
| sexually transmitted disease | 0.35131 |
| hepatitis c virus | 0.843198 |
| acute infection | 0.369302 |
| Hepatitis C. | 0.595129 |
| chronic infection | 0.413937 |
| person | 0.363298 |
| chronic disease | 0.34823 |
|
| liver problems | 0.42407 |
| long-term liver problems | 0.400413 |
| liver enzyme levels | 0.390149 |
| poor infection-control practices | 0.350676 |
| United States | 0.435749 |
| liver function | 0.366125 |
| additional liver damage | 0.380811 |
| multiple sex partners | 0.351437 |
| cause hepatitis | 0.516499 |
| commercial tattooing facilities | 0.351739 |
| virus infections | 0.372233 |
| viral hepatitis | 0.529166 |
| infected household member | 0.36981 |
| chronic Hepatitis C. | 0.508531 |
| hepatitis | 0.930493 |
| people | 0.409028 |
| blood | 0.383401 |
| virus infection | 0.458113 |
| virus infection state | 0.400841 |
| infected person | 0.355085 |
| chronic hepatitis | 0.704542 |
| liver cancer | 0.408201 |
| major research studies | 0.351447 |
| infected persons | 0.346216 |
|
CLICK HERE |
| 15403 |
Centers for Disease Control and Prevention |
Html |
en |
Impact of Health Insurance Expansions on Nonelderly AdultsWith Hypertension |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| lifetime health events | 0.460049 |
| health insurance | 0.937285 |
| myocardial infarction | 0.454954 |
| systolic blood pressure | 0.511713 |
| CVD-related mortality rates | 0.43261 |
| insurance coverage | 0.854085 |
| hypertensive patients | 0.454575 |
| diastolic blood pressure | 0.435057 |
| health insurance rates | 0.501773 |
| new CVD events | 0.461577 |
| CVD prevention strategies | 0.447273 |
| insurance expansions | 0.758014 |
| CVD risk groups | 0.461735 |
| health insurance coverage | 0.673278 |
| blood pressure | 0.878988 |
| risk factors | 0.490884 |
| fewer CVD events | 0.477826 |
| cardiovascular disease risk | 0.484208 |
| insurance status | 0.515644 |
| Affordable Care Act | 0.452712 |
| American Heart Association | 0.574541 |
| CVD incidence rates | 0.482544 |
| CVD-related deaths | 0.463583 |
| antihypertensive medications | 0.550595 |
|
| health benefits | 0.512815 |
| CVD events | 0.593195 |
| health effects | 0.483484 |
| health insurance rate | 0.462786 |
| Framingham CVD risk | 0.535985 |
| CVD risk functions | 0.538331 |
| United States | 0.45084 |
| improved hypertension treatment | 0.515674 |
| Insurance coverage levels | 0.436622 |
| health insurance expansions | 0.747252 |
| fewer CHD cases | 0.442747 |
| cardiovascular disease | 0.634617 |
| hypertension treatment rates | 0.569561 |
| expansion scenario | 0.455686 |
| averted CVD events | 0.453041 |
| Health insurance status | 0.451025 |
| population-level CVD incidence | 0.444156 |
| post-ACA insurance rates | 0.433243 |
| greater health effects | 0.472595 |
| Health Insurance Marketplaces | 0.47368 |
| CVD disease | 0.431942 |
| et al | 0.573232 |
| coronary heart disease | 0.622828 |
| CVD risk factors | 0.471406 |
|
CLICK HERE |
| 15556 |
Centers for Disease Control and Prevention |
Html |
en |
What Is the National DPP? |
National Diabetes Prevention Program |
| prevention program | 0.238594 |
| lifestyle change programs | 0.869514 |
| overall health | 0.251367 |
| diabetes prevention efforts | 0.304888 |
| Prevent Diabetes STAT | 0.38602 |
| lifestyle change program | 0.374789 |
| lifestyle coach | 0.218524 |
| National DPP | 0.911561 |
| Research-Based Prevention Program | 0.22861 |
| National Diabetes Prevention | 0.333636 |
|
| online CDC-recognized lifestyle | 0.269295 |
| CDC-recognized lifestyle change | 0.4518 |
| lasting lifestyle changes | 0.282267 |
| National DPP Infographic | 0.510621 |
| online lifestyle change | 0.283756 |
| nationwide teach participants | 0.228048 |
| public awareness campaign | 0.226045 |
| American Diabetes Association | 0.282812 |
| health care providers | 0.222582 |
|
CLICK HERE |